Literature DB >> 23519412

The structure of the ARE-binding domains of Hu antigen R (HuR) undergoes conformational changes during RNA binding.

Hong Wang1, Fuxing Zeng, Qiao Liu, Huihui Liu, Zexian Liu, Liwen Niu, Maikun Teng, Xu Li.   

Abstract

Human RNA-binding protein (HuR), a ubiquitously expressed member of the Hu protein family, plays an important role in mRNA degradation and has been implicated as a key post-transcriptional regulator. HuR contains three RNA-recognition motif (RRM) domains. The two N-terminal tandem RRM domains can selectively bind AU-rich elements (AREs), while the third RRM domain (RRM3) contributes to interactions with the poly-A tail of target mRNA and other ligands. Here, the X-ray structure of two methylated tandem RRM domains (RRM1/2) of HuR in their RNA-free form was solved at 2.9 Å resolution. The crystal structure of RRM1/2 complexed with target mRNA was also solved at 2.0 Å resolution; comparisons of the two structures show that HuR RRM1/2 undergoes conformational changes upon RNA binding. Fluorescence polarization assays (FPA) were used to study the protein-RNA interactions. Both the structure and the FPA analysis indicated that RRM1 is the primary ARE-binding domain in HuR and that the conformational changes induce subsequent contacts of the RNA substrate with the inter-domain linker and RRM2 which greatly improve the RNA-binding affinity of HuR.

Entities:  

Keywords:  HuR; RNA binding; RRM; conformational change

Mesh:

Substances:

Year:  2013        PMID: 23519412     DOI: 10.1107/S0907444912047828

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  37 in total

Review 1.  Musashi RNA-Binding Proteins as Cancer Drivers and Novel Therapeutic Targets.

Authors:  Alexander E Kudinov; John Karanicolas; Erica A Golemis; Yanis Boumber
Journal:  Clin Cancer Res       Date:  2017-01-31       Impact factor: 12.531

2.  Novel Compounds Targeting the RNA-Binding Protein HuR. Structure-Based Design, Synthesis, and Interaction Studies.

Authors:  Serena Della Volpe; Rita Nasti; Michele Queirolo; M Yagiz Unver; Varsha K Jumde; Alexander Dömling; Francesca Vasile; Donatella Potenza; Francesca Alessandra Ambrosio; Giosué Costa; Stefano Alcaro; Chiara Zucal; Alessandro Provenzani; Marcello Di Giacomo; Daniela Rossi; Anna K H Hirsch; Simona Collina
Journal:  ACS Med Chem Lett       Date:  2019-01-21       Impact factor: 4.345

3.  Structural study of the Fox-1 RRM protein hydration reveals a role for key water molecules in RRM-RNA recognition.

Authors:  Miroslav Krepl; Markus Blatter; Antoine Cléry; Fred F Damberger; Frédéric H T Allain; Jiri Sponer
Journal:  Nucleic Acids Res       Date:  2017-07-27       Impact factor: 16.971

4.  Identification of novel proteins binding the AU-rich element of α-prothymosin mRNA through the selection of open reading frames (RIDome).

Authors:  Laura Patrucco; Clelia Peano; Andrea Chiesa; Filomena Guida; Imma Luisi; Ilenia Boria; Flavio Mignone; Gianluca De Bellis; Silvia Zucchelli; Stefano Gustincich; Claudio Santoro; Daniele Sblattero; Diego Cotella
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

5.  The C-terminal RNA binding motif of HuR is a multi-functional domain leading to HuR oligomerization and binding to U-rich RNA targets.

Authors:  Rafael M Scheiba; Alain Ibáñez de Opakua; Antonio Díaz-Quintana; Isabel Cruz-Gallardo; Luis A Martínez-Cruz; María L Martínez-Chantar; Francisco J Blanco; Irene Díaz-Moreno
Journal:  RNA Biol       Date:  2014       Impact factor: 4.652

6.  BOPC1 Enantiomers Preparation and HuR Interaction Study. From Molecular Modeling to a Curious DEEP-STD NMR Application.

Authors:  Serena Della Volpe; Roberta Listro; Michela Parafioriti; Marcello Di Giacomo; Daniela Rossi; Francesca Alessandra Ambrosio; Giosuè Costa; Stefano Alcaro; Francesco Ortuso; Anna K H Hirsch; Francesca Vasile; Simona Collina
Journal:  ACS Med Chem Lett       Date:  2020-01-28       Impact factor: 4.345

7.  Combined treatment of human multiple myeloma cells with bortezomib and doxorubicin alters the interactome of 20S proteasomes.

Authors:  Alexey G Mittenberg; Valeria O Kuzyk; Sergey V Shabelnikov; Daria P Gorbach; Alla N Shatrova; Olga A Fedorova; Nickolai A Barlev
Journal:  Cell Cycle       Date:  2018-08-01       Impact factor: 4.534

8.  A 1536-well fluorescence polarization assay to screen for modulators of the MUSASHI family of RNA-binding proteins.

Authors:  Gerard Minuesa; Christophe Antczak; David Shum; Constantin Radu; Bhavneet Bhinder; Yueming Li; Hakim Djaballah; Michael G Kharas
Journal:  Comb Chem High Throughput Screen       Date:  2014       Impact factor: 1.339

Review 9.  Understanding and targeting the disease-related RNA binding protein human antigen R (HuR).

Authors:  Christopher W Schultz; Ranjan Preet; Teena Dhir; Dan A Dixon; Jonathan R Brody
Journal:  Wiley Interdiscip Rev RNA       Date:  2020-01-23       Impact factor: 9.957

Review 10.  Can we observe changes in mRNA "state"? Overview of methods to study mRNA interactions with regulatory proteins relevant in cancer related processes.

Authors:  C Zurla; J Jung; P J Santangelo
Journal:  Analyst       Date:  2016-01-21       Impact factor: 4.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.